These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37409015)

  • 1. Benefits and risks of antiplatelet therapy for moyamoya disease: a systematic review and meta-analysis.
    Liu T; Qin M; Xiong X; Li T; Feng L; Lai X; Gao Y
    Front Neurol; 2023; 14():1132339. PubMed ID: 37409015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet Treatment in Moyamoya Disease: A Systematic Review.
    Kijpaisalratana N; Ariyaprakai C; Sriamornrattanakul K; Wongsuriyanan S; Akharathammachote N; Susantitaphong P; Suwanwela NC
    Cerebrovasc Dis Extra; 2024; 14(1):76-85. PubMed ID: 38697036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet therapy may improve the prognosis of patients with moyamoya disease: a 12-year retrospective study.
    Luo Y; Cao Z; Ye H; Wu S; Sun X
    J Neurol; 2023 Aug; 270(8):3876-3884. PubMed ID: 37106259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for postoperative stroke in adults patients with moyamoya disease: a systematic review with meta-analysis.
    Wei W; Chen X; Yu J; Li XQ
    BMC Neurol; 2019 May; 19(1):98. PubMed ID: 31092214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemorrhagic Moyamoya Disease Treatment: A Network Meta-Analysis.
    Ding J; Zhou D; Paul Cosky EE; Pan L; Ya J; Wang Z; Jin K; Guan J; Ding Y; Ji X; Meng R
    World Neurosurg; 2018 Sep; 117():e557-e562. PubMed ID: 29933090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
    Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
    J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic therapy for secondary prevention in patients with stroke or transient ischemic attack: A multiple treatment network meta-analysis of randomized controlled trials.
    Tornyos D; Komócsi A; Bálint A; Kupó P; El Abdallaoui OEA; Szapáry L; Szapáry LB
    PLoS One; 2022; 17(8):e0273103. PubMed ID: 35976963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease.
    Ye F; Li J; Wang T; Lan K; Li H; Yin H; Guo T; Zhang X; Yang T; Liang J; Wu X; Li Q; Sheng W
    Front Neurol; 2020; 11():608000. PubMed ID: 33519687
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous thrombolysis and endovascular thrombectomy for acute ischaemic stroke in patients with Moyamoya disease - a systematic review and meta-summary of case reports.
    Koh MY; Toh KZ; Ho JS; Yeo LL; Ho AF; Sia CH; Tan BY
    J Thromb Thrombolysis; 2022 Aug; 54(2):339-349. PubMed ID: 35699873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Efficacy of Surgical Treatment for the Secondary Prevention of Stroke in Symptomatic Moyamoya Disease: A Meta-Analysis.
    Qian C; Yu X; Li J; Chen J; Wang L; Chen G
    Medicine (Baltimore); 2015 Dec; 94(49):e2218. PubMed ID: 26656359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Surgical Treatment on the Recurrent Stroke Prevention for Adult Patients With Hemorrhagic Moyamoya Disease.
    Wang G; Zhang X; Feng M; Liu X; Guo F
    J Craniofac Surg; 2017 Nov; 28(8):2113-2116. PubMed ID: 29088693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis.
    Del Giovane C; Boncoraglio GB; Bertù L; Banzi R; Tramacere I
    BMC Neurol; 2021 Aug; 21(1):319. PubMed ID: 34399713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review.
    Lane DA; Raichand S; Moore D; Connock M; Fry-Smith A; Fitzmaurice DA;
    Health Technol Assess; 2013 Jul; 17(30):1-188. PubMed ID: 23880057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antiplatelet treatment on aneurysmal subarachnoid hemorrhage patients after endovascular treatment: a systematic review with meta-analysis.
    Zhao L; Lin P; Zhang Y; Huang XY; Li HY; Xia MK; Huang X; Li Z; Zhou LX; Tang XP
    Neurosurg Rev; 2022 Dec; 45(6):3523-3536. PubMed ID: 36178562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Associations of Cognitive Impairment in Adult Patients with Moyamoya Disease: A Systematic Review and Meta-Analysis.
    Toh KZX; Koh MY; Loh EDW; Sia CH; Chong Y; Yeo LLL; Sharma VK; Lim MJR; Tan BYQ
    J Alzheimers Dis; 2024; 97(2):541-552. PubMed ID: 38108354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrovascular events after surgery versus conservative therapy for moyamoya disease: a meta-analysis.
    Wouters A; Smets I; Van den Noortgate W; Steinberg GK; Lemmens R
    Acta Neurol Belg; 2019 Sep; 119(3):305-313. PubMed ID: 31215004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-Analysis of the Association Between Asthma and the Risk of Stroke.
    Fang ZH; Li ZF; An ZY; Huang SC; Hao MD; Zhang WX
    Front Neurol; 2022; 13():900438. PubMed ID: 35812117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of the surgical outcomes of symptomatic moyamoya disease in adults.
    Jeon JP; Kim JE; Cho WS; Bang JS; Son YJ; Oh CW
    J Neurosurg; 2018 Mar; 128(3):793-799. PubMed ID: 28474994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors.
    Unda SR; Antoniazzi AM; Miller R; Klyde D; Javed K; Fluss R; Holland R; De la Garza Ramos R; Haranhalli N; Altschul DJ
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105965. PubMed ID: 34247053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.